- Product Usage: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
Tirzepatide is a synthetic dual-agonist peptide designed to activate both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. In preclinical and translational research settings, it has been studied for its role in glucose regulation, appetite signaling, and metabolic efficiency, making it a compound of interest in metabolic and endocrine research models.
$75.00
- Products will arrive in a lyophilized (powder) form for maximum stability
Tirzepatide is a synthetic dual-agonist peptide designed to activate both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. In preclinical and translational research settings, it has been studied for its role in glucose regulation, appetite signaling, and metabolic efficiency, making it a compound of interest in metabolic and endocrine research models.
$75.00
- Products will arrive in a lyophilized (powder) form for maximum stability
-
Description
Tirzepatide is a synthetic dual-agonist peptide designed to activate both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. In preclinical and translational research settings, it has been studied for its role in glucose regulation, appetite signaling, and metabolic efficiency, making it a compound of interest in metabolic and endocrine research models.
Research Focus
Tirzepatide is commonly explored in laboratory research involving:
- GLP-1 and GIP receptor pathway signaling
- Glucose and insulin homeostasis models
- Appetite and satiety regulation research
- Energy balance and metabolic efficiency studies
- Obesity and metabolic dysfunction research
Research-Observed Effects
Preclinical studies suggest Tirzepatide may support:
- Integrated incretin-based metabolic signaling
- Regulation of glucose and appetite-related pathways
- Enhanced metabolic efficiency in research models
Findings are based on laboratory and experimental research only.
Product Specifications
- Peptide:
Tirzepatide - Type:
Synthetic dual GLP-1 / GIP receptor agonist - Molecular Formula:
C₂₂₅H₃₄₈N₄₈O₆₈ - Molecular Weight:
~4,814 g/mol - CAS Number:
2023788-19-2 - Purity:
≥99% (HPLC Verified) - Form:
Lyophilized powder
Quality & Compliance
- HPLC & MS verified
- Manufactured under controlled conditions
- For Research Use Only (RUO)
- Not for human or veterinary use
⚠️ This product is intended strictly for research purposes only and is not approved for human or veterinary use.